ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Obese Men With Benign Biopsy At High Risk for Prostate Cancer

April 26, 2013

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

MRI Reveals Information That May Alter Treatment

December 28, 2007

BSA Approves Concept For Ovarian Cancer SPORE Grant

June 26, 1998

Faulty Estimates Led NCI To Overstate Black-White Cancer Disparity In Atlanta

September 20, 2002

Hammer Agrees To Bush Request for FDA Probe

July 15, 1988